Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers

ClinicalTrials.gov ID: NCT02563522

Public ClinicalTrials.gov record NCT02563522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)

Study identification

NCT ID
NCT02563522
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Helixmith Co., Ltd.
Industry
Enrollment
44 participants

Conditions and interventions

Interventions

  • Engensis (VM202) Genetic
  • Placebo Drug

Genetic · Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2017
Primary completion
Sep 23, 2019
Completion
Sep 23, 2019
Last update posted
Oct 8, 2025

2017 – 2019

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Central Research Associates, Inc. Birmingham Alabama 35205
Arizona Research Center Phoenix Arizona 85053
University of Arizona Tucson Arizona 85724
NEA Baptist Jonesboro Arkansas 72401
Sacramento Foot and Ankle Carmichael California 95608
Bay Area Foot and Ankle Castro Valley California 94546
VA Long Beach Healthcare System Long Beach California 90822
USC Keck School of Medicine Los Angeles California 90033
Foot and Ankle Clinic Los Angeles California 90057
Center for Clinical Research Inc. San Francisco California 94115
Olive View-UCLA Education & Research Institute Sylmar California 91342
LCC Medical Research Institute Miami Florida 33126
Miami Dade Medical Research Institute, LLC Miami Florida 33176
Northwestern University Chicago Illinois 60611
UMASS Memorial Med Center Worcester Massachusetts 01655
Saint Louis University St Louis Missouri 63110
Advanced Foot & Ankle Center Las Vegas Nevada 89119
Oregon Foot and Ankle Center Eugene Oregon 97401
MedResearch, Inc El Paso Texas 79932
Acclaim Bone & Joint Institute Fort Worth Texas 76107
Texas Heart Institute Houston Texas 77030
Futuro Clinical Trials McAllen Texas 78501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02563522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02563522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →